Morelli, Mariangela; Lessi, Francesca; Barachini, Serena; Liotti, Romano; Montemurro, Nicola; Perrini, Paolo; Santonocito, Orazio Santo; Gambacciani, Carlo; Snuderl, Matija; Pieri, Francesco; Aquila, Filippo; Farnesi, Azzurra; Naccarato, Antonio Giuseppe; Viacava, Paolo; Cardarelli, Francesco; Ferri, Gianmarco; Mulholland, Paul; Ottaviani, Diego; Paiar, Fabiola; Liberti, Gaetano; Pasqualetti, Francesco; Menicagli, Michele; Aretini, Paolo; Signore, Giovanni; Franceschi, Sara; Mazzanti, Chiara Maria

Loss of ARID1A Expression Predicts Poor Prognosis in High Grade Skeletal Osteosarcoma

LABORATORY INVESTIGATION

IF4.2

2025-03-010

PRE

Insights from Multigene Panel Sequencing and Comparative Analysis of Metaplastic Carcinoma of the Breast

LABORATORY INVESTIGATION

IF4.2

2025-03-010

PRE

Sedoheptulose Kinase SHPK Expression in Glioblastoma: Emerging Role of the Nonoxidative Pentose Phosphate Pathway in Tumor Proliferation (vol 23, 5978, 2022)

Sedoheptulose Kinase SHPK 在胶质母细胞瘤中的表达：戊糖磷酸途径非氧化支路在肿瘤增殖中的新兴作用 (vol 23, 5978, 2022)

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

IF4.9

2025-01-260

Whole-exome sequencing to identify causative variants in cases of sudden cardiac death below 50 years

EUROPEAN HEART JOURNAL

IF35.6

2024-10-280

PRE

DECIPHERING GLIOBLASTOMA METABOLIC SIGNATURE: MOLECULAR PROFILING AND NADH-FLIM IMAGING

NEURO-ONCOLOGY

IF13.4

2024-10-170

PRE

UTILIZING HIGH-THROUGHPUT SCREENING PLATFORMS FOR PROFILING DRUG SENSITIVITY ACROSS MULTIPLE CANCER CELL LINES TO UNLOCK NEW TARGETED THERAPIES IN GLIOBLASTOMA

NEURO-ONCOLOGY

IF13.4

2024-10-170

PRE

BEYOND THE EXPECTED: CIRCULATING TUMOR CELLS IN GLIOBLASTOMA REVEAL HIDDEN HETEROGENEITY AND BECOME POTENTIAL DIAGNOSTIC BIOMARKERS

NEURO-ONCOLOGY

IF13.4

2024-10-170

PRE

Whole-exome sequencing to identify causative variants in juvenile sudden cardiac death

HUMAN GENOMICS

IF4.3

2024-09-161

OAAI

Comparative analysis of genetic variants in pleural fluids and solid tissue biopsies of pleural mesothelioma patients: Implications for molecular heterogeneity assessment

HELIYON

IF3.6

2024-06-011

OAAI

Exploring Regorafenib Responsiveness and Uncovering Molecular Mechanisms in Recurrent Glioblastoma Tumors through Longitudinal In Vitro Sampling

CELLS

IF5.2

2024-03-112

OAAI

BIRC3 AS A PREDICTOR OF OUTCOME AND A NEW THERAPEUTIC TARGET IN TMZ RESISTANT GLIOBLASTOMA TUMORS

NEURO-ONCOLOGY

IF13.4

2023-09-080

PRE

INVESTIGATION OF REGORAFENIB TUMOR SENSITIVITY AND UNDERLYING TREATMENT INDUCED MOLECULAR MECHANISMS IN GLIOBLASTOMA RECURRENT TUMORS

NEURO-ONCOLOGY

IF13.4

2023-09-080

CIRCULATING TUMOR CELLS AS A NON-INVASIVE GLIOBLASTOMA DIAGNOSTIC AND PROGNOSTIC TOOL

NEURO-ONCOLOGY

IF13.4

2023-09-080

PRE

Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency

HAEMATOLOGICA

IF7.9

2023-02-233

OAAI

Marin-Bejar, Oskar; Romero-Moya, Damia; Rodriguez-Ubreva, Javier; Distefano, Maximiliano; Lessi, Francesca; Aretini, Paolo; Liquori, Alessandro; Castano, Julio; Kozyra, Emilia; Kotmayer, Lili; Bueno, Clara; Cervera, Jose; Rodriguez-Gallego, Jose Carlos; Nomdedeu, Josep F.; Murillo-Sanjuan, Laura; Diaz de Heredia, Cristina; Perez-Martinez, Antonio; Lopez-Cadenas, Felix; Martinez-Laperche, Carolina; Dorado-Herrero, Nieves; Marco, Francisco M.; Prosper, Felipe; Menendez, Pablo; Valcarcel, David; Ballestar, Esteban; Bodor, Csaba; Bigas, Anna; Catala, Albert; Wlodarski, Marcin W.; Giorgetti, Alessandra

Paolo Aretini

个人简介

教育背景

工作经历

荣誉奖项

研究方向